RXMP THERAPEUTICS
RxMP Therapeutics is a pharmaceutical company that is focused on developing proprietary drugs for the management of excessive bleeding. They aim to develop and commercialize RMP-HPE, (red cell-derived microparticles produced by high-pressure extrusion), as a new hemostatic agent for the treatment or prevention of excessive bleeding.
RXMP THERAPEUTICS
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2013-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.rxmptherapeutics.com
Total Employee:
1+
Status:
Closed
Contact:
12156280938
Email Addresses:
[email protected]
Total Funding:
1.31 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft DNS
Current Employees Featured
Founder
Investors List
Florida Institute for the Commercialization of Florida Technology
Florida Institute for the Commercialization of Florida Technology investment in Venture Round - RxMP Therapeutics
Florida Institute for the Commercialization of Florida Technology
Florida Institute for the Commercialization of Florida Technology investment in Seed Round - RxMP Therapeutics
Official Site Inspections
http://www.rxmptherapeutics.com
- Host name: merlinsg3.ixtopia.net
- IP address: 67.202.239.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RxMP Therapeutics"
About Us – RxMP Therapeutics, INC
Director of Clinical Thromboembolism Program, Prof. Medicine, McMaster Univ. (Volunteer SAB Member)See details»
RxMP Therapeutics - Crunchbase Company Profile & Funding
RxMP Therapeutics is a pharmaceutical company that is focused on developing proprietary drugs for the management of excessive bleeding. They aim to develop and commercialize RMP …See details»
About — RxMP Therapeutics, INC
RxMP is dedicated to developing innovative therapies to prevent and treat hemorrhage and excessive bleeding. Our platform technology capitalizes on the finding that RMPs, when …See details»
RxMP Therapeutics, INC
RxMP Therapeutics is developing novel systemically-delivered hemostatic agents that are designed to arrest or prevent excessive bleeding, with the goal of improving healthcare outcomes while reducing costs and the need for …See details»
Our Team - RxMP Therapeutics, INC
Co-Director, Cardiothoracic Surgical Intensive Care Unit.See details»
RxMP Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for RxMP Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
RxMP Therapeutics, Inc. - BIO International Convention | BIO
Jun 5, 2023 · RxMP aims to develop and commercialize red cell-derived microparticles produced by high-pressure extrusion (“RMP-HPEs”) as a novel first-in-class systemic hemostatic agent …See details»
RxMP Therapeutics - Funding, Financials, Valuation & Investors
RxMP Therapeutics is funded by Florida Institute for the Commercialization of Florida Technology. Which investors participated in the most funding rounds? RxMP Therapeutics is a …See details»
RxMP Therapeutics - Contacts, Employees, Board Members
RxMP Therapeutics has 1 current employee profile, President, CEO & Managing Director Rifat Pamukcu. RxMP Therapeutics is a pharmaceutical company that is focused on developing …See details»
RxMP Therapeutics - Products, Competitors, Financials, Employees ...
RxMP Therapeutics (RxMP) is an emerging specialty pharmaceutical company focused on developing proprietary drugs for the management of excessive bleeding. Use the CB Insights …See details»
Technology/Products – RxMP Therapeutics, INC
RMPs are administered systemically and can be used either therapeutically or prophylactically prior to surgical procedures with a high risk of significant blood loss. RMPs hold the potential for single agent use or for use as a complement …See details»
Our Science — RxMP Therapeutics, INC
RMPs provide complex negatively-charged membranes that support coagulation by serving as sites for the assembly of clotting factors to generate thrombin as well as enhancing platelet …See details»
RXMP THERAPEUTICS, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for RXMP THERAPEUTICS, LLC of Miami, FL. Get the latest business insights from Dun & Bradstreet.See details»
RxMP Therapeutics - VentureRadar
RxMP Therapeutics VentureRadar profile. Find out more about RxMP Therapeutics, Medical Devices.See details»
RxMP Therapeutics - Overview, News & Similar companies
Who is RxMP Therapeutics. RxMP Therapeutics is developing novel hemostatic agents that are designed to arrest or prevent excessive bleeding, thus reducing the need for trans fused …See details»
Novel First-in-Class Blood Clotting Agent Takes Shape as Bloody ...
Jan 11, 2021 · RxMP Therapeutics Inc. is ready to move its lead agent through proof of concept using intracranial hemorrhage, from either hemorrhagic stroke or subarachnoid hemorrhage, …See details»
Rifat Pamukcu – Virion Therapeutics
Dr. Rifat Pamukcu is Chairman, President & Chief Executive Officer of RxMP Therapeutics, Inc.. Pamukcu was previously a Founder, Director, and Chief Scientific Officer of Cell Pathways, …See details»
News — RxMP Therapeutics, INC
Feb 23, 2024 · RxMP Therapeutics featured again on BioPub. Dr. Rif Pamukcu CEO and Dr. Mike Davis, former Director of the U.S. Combat Casualty Care Research Program, give …See details»
Working at RxMP Therapeutics - Glassdoor
Glassdoor gives you an inside look at what it's like to work at RxMP Therapeutics, including salaries, reviews, office photos, and more. This is the RxMP Therapeutics company profile. All …See details»
Abstract WP460: Use of Red Cell Microparticles to Limit …
Jan 30, 2019 · In the present study, we determined the efficacy of RMP in reducing hematoma expansion in a rat model of collagenase-induced sICH. RMPs were prepared from human …See details»